Infertility Drugs Market

In order to treat infertility problems among the population there are many dugs present in the market such as Clomiphene (Clomid), Letrozole (Femara), Gonadotropins, etc. These drugs are used to trigger ovulation or to trigger hormones for proper functioning of ovaries. According to data published in 2018, in Shady Grove Fertility, Clomiphene is being prescribed by doctors for more than 50 years and still being extensively used to treat infertility cases in women. High blood sugar levels and Poly Cystic Ovarian Syndrome (PCOS) also interferes in sustaining pregnancy. To control the blood sugar and PCOS Metformin is highly prescribed drug. Metformin is sold under the brand name of Glucophage, Glumetza, Glucophage XR, and Fortamet.

Market Dynamics

Increasing prevalence of infertility in couples is highly contributing to infertility drugs market size. For instance, According to Centres for Disease Control and Prevention (CDC) report of 2018, about 6% of women aged 15 to 44 years in the U.S. were unable to get pregnant after one year of trying (infertility). Also, about 12% of women aged 15 to 44 years in the U.S. have difficulty getting pregnant or carrying a pregnancy to term. Infertility also affects rising number of men. According to the same source, almost 9% of men aged 25 to 44 years in the U.S. reported that they required medical help for reproduction.

The restraining factors for the infertility drug market growth is the potential risks of infertility drugs. Risks of infertility includes pregnancy with multiples, ovarian hyper-stimulation syndrome, long-term risks of ovarian tumours etc. According to the data published by Mayo Clinic Organisation in 2018, oral medications have less risk of multiples pregnancy (less than 10 percent) and mostly a risk of twins. And according to the same source, chances increase up to 30 percent with injectable medications. Injectable fertility medications also carry the major risk of triplets or more (higher order multiple pregnancy).

Key features of the study:

• This report provides in-depth analysis of the infertility drugs market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
• It profiles key players in the global infertility drugs market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

• Key players covered as a part of this study include Merck & Co., Ferring Pharmaceuticals, LIVZON Pharmaceutical Group Inc., Abbott Laboratories, Bayer AG, and Zydus Pharmaceuticals

• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• The global infertility drugs market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for infertility drugs market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

• Global Infertility Drugs Market, By Drug Type:

• Clomiphene citrate
• Sex hormones

• Estrogen
• Progesterone
• Testosterone

• Gonadotropins
• Bromocriptine
• Cabergoline
• Imipramine
• Letrozole
• Metformin

• Global Infertility Drugs Market, By Route of Administration:
• Oral
• Intravenous
• Subcutaneous
• Intramuscular
• Global Infertility Drugs Market, By Gender:
• Male
• Female
• Global Infertility Drugs Market, By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Global Infertility Drugs Market, By Region:
• North America
• By Country:
• U.S.
• Canada
• By Drug Type:
• Clomiphene citrate
• Sex Hormones
• Estrogen
• Progesterone
• Testosterone
• Gonadotropins
• Bromocriptine
• Cabergoline
• Imipramine
• Letrozole
• Metformin      
• By Route of Administration:
• Oral
• Intravenous
• Subcutaneous
• Intramuscular
• By Gender:
• Male
• Female
• By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Europe
• By Country:
• U.K.
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe
• By Drug Type:
• Clomiphene citrate
• Sex Hormones
• Estrogen
• Progesterone
• Testosterone
• Gonadotropins
• Bromocriptine
• Cabergoline
• Imipramine
• Letrozole
• Metformin      
• By Route of Administration:
• Oral
• Intravenous
• Subcutaneous
• Intramuscular
• By Gender:
• Male
• Female
• By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Asia Pacific
• By Country:
• Australia
• India
• China
• Japan
• ASEAN
• South Korea
• Rest of Asia Pacific
• By Drug Type:
• Clomiphene citrate
• Sex Hormones
• Estrogen
• Progesterone
• Testosterone
• Gonadotropins
• Bromocriptine
• Cabergoline
• Imipramine
• Letrozole
• Metformin      
• By Route of Administration:
• Oral
• Intravenous
• Subcutaneous
• Intramuscular
• By Gender:
• Male
• Female
• By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Latin America
• By Country:
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• By Drug Type:
• Clomiphene citrate
• Sex Hormones
• Estrogen
• Progesterone
• Testosterone
• Gonadotropins
• Bromocriptine
• Cabergoline
• Imipramine
• Letrozole
• Metformin      
• By Route of Administration:
• Oral
• Intravenous
• Subcutaneous
• Intramuscular
• By Gender:
• Male
• Female
• By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Middle East
• By Country:
• GCC
• Israel
• Rest of Middle East
• By Drug Type:
• Clomiphene citrate
• Sex Hormones
• Estrogen
• Progesterone
• Testosterone
• Gonadotropins
• Bromocriptine
• Cabergoline
• Imipramine
• Letrozole
• Metformin      
• By Route of Administration:
• Oral
• Intravenous
• Subcutaneous
• Intramuscular
• By Gender:
• Male
• Female
• By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Africa
• By Country:
• South Africa
• Central Africa
• North Africa
• By Drug Type:
• Clomiphene citrate
• Sex Hormones
• Estrogen
• Progesterone
• Testosterone
• Gonadotropins
• Bromocriptine
• Cabergoline
• Imipramine
• Letrozole
• Metformin      
• By Route of Administration:
• Oral
• Intravenous
• Subcutaneous
• Intramuscular
• By Gender:
• Male
• Female
• By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Company Profiles
• Merck & Co.*
• Company Overview
• Product Portfolio
• Financial Performance
• Recent Highlights
• Strategies
• Ferring Pharmaceuticals
• LIVZON Pharmaceutical Group Inc.
• Abbott Laboratories
• Bayer AG
• Zydus Pharmaceuticals

“*” marked represents similar segmentation in other categories in the respective section.